Please login to the form below

Not currently logged in


This page shows the latest AZD1222 news and features for those working in and with pharma, biotech and healthcare.

AZ/Oxford COVID-19 vaccine hits primary efficacy endpoint in US-based trial

AZ/Oxford COVID-19 vaccine hits primary efficacy endpoint in US-based trial

In an interim analysis, the vaccine – also known as AZD1222 – demonstrated a vaccine efficacy of 79% at preventing symptomatic COVID-19, as well as 100% efficacy at preventing severe disease and ... Although the US trial administered two doses of

Latest news

More from news
Approximately 7 fully matching, plus 20 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....